Enbrel and Warfarin Interaction Risk Assessment

Primary Risk: Additive Bleeding Potential

• Warfarin monotherapy carries inherent bleeding risks, with gastrointestinal and intracranial bleeding being most concerning in older adults, according to the European Heart Journal 1, 2
• The risk of major bleeding is significantly elevated when warfarin is combined with other medications that affect hemostasis, as reported in Circulation 3
• Maintaining INR within therapeutic range (2.0-3.0 for most indications) is critical, though bleeding can occur even with therapeutic INR levels, as noted in the Journal of the American Geriatrics Society and Annals of Oncology 4, 5

Monitoring and Management Strategy

• Continue standard INR monitoring at the frequency appropriate for the patient's warfarin stability, as recommended by the Journal of the American Geriatrics Society 4
• Monitor INR more closely if the patient is on additional interacting medications (NSAIDs, antibiotics, antiplatelets), according to the European Heart Journal and Circulation: Arrhythmia and Electrophysiology 1, 2, 6

Critical Drug Combinations to Avoid

• NSAIDs (including COX-2 inhibitors) increase bleeding risk 1.8-3.1 fold when combined with warfarin, as reported in the European Heart Journal 1, 2
• Antiplatelet agents, such as aspirin and clopidogrel, increase bleeding risk when combined with warfarin, according to Circulation 3
• Certain antibiotics, such as fluoroquinolones, macrolides, and tetracyclines, can potentiate warfarin effects through CYP2C9 inhibition or gut flora alteration, as noted in Circulation: Arrhythmia and Electrophysiology and other sources 6, 7

Special Populations

• Elderly patients (≥75 years) have higher risk of both gastrointestinal and intracranial bleeding with warfarin therapy, and may require reduced warfarin dosing with periodic INR monitoring, as recommended by the European Heart Journal 1, 2
• Patients with renal impairment, hepatic dysfunction, and heart failure all increase warfarin-related bleeding risk, according to the European Heart Journal and Journal of the American Geriatrics Society 1, 4

When to Consider Alternative Anticoagulation

• Direct oral anticoagulants (DOACs) may be considered as alternatives to warfarin in appropriate patients, as they have fewer drug-drug interactions overall and no requirement for routine monitoring, as reported in Circulation: Arrhythmia and Electrophysiology and the European Heart Journal 2, 6